J&J Backs Off 340B Rebate Plan Following Feds' Objections

By Dan McKay · September 30, 2024, 8:05 PM EDT

Johnson & Johnson abandoned its plan Monday to offer rebates rather than upfront discounts for two medications under the 340B drug pricing law, contending it had no choice after a federal...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login